Novo Nordisk will continue to push forward, implementing countermeasures such as advancing more commercial initiatives, while expecting to receive a regulatory decision on Wegovy for metabolic dysfunction associated steatohepatitis (MASH) during H2 2025, which would represent a new growth driver
If you may be physically dependent on alcohol, do not try to stop suddenly without medical guidance
Families considering GLP-1 therapy for a teenager should understand that any such treatment falls outside formal FDA authorization and requires a thorough risk-benefit discussion with a pediatric endocrinologist or obesity specialist
Glia monsters are venomous lizard native to the southwestern United States and northern Mexico
Dysregulation of glutaminase and glutamine synthetase in cancer
Brain-Focused Pills (e.g., Qsymia, Contrave) Affect appetite and metabolism through brain pathways